In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance.
about
Breast Milk and Solid Food Shaping Intestinal ImmunityAtorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP.Targeting latency-associated peptide promotes antitumor immunity.The Effects of Anti-LAP Monoclonal Antibody Down-regulation of CD4+LAP+ T Cells on Allogeneic Corneal Transplantation in Mice.CD3+CD4+LAP+Foxp3-Regulatory Cells of the Colonic Lamina Propria Limit Disease Extension in Ulcerative Colitis
P2860
In vivo anti-LAP mAb enhances IL-17/IFN-γ responses and abrogates anti-CD3-induced oral tolerance.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@ast
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@en
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@nl
type
label
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@ast
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@en
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@nl
prefLabel
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@ast
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@en
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@nl
P2093
P2860
P356
P1476
In vivo anti-LAP mAb enhances ...... ti-CD3-induced oral tolerance.
@en
P2093
Andre P da Cunha
Henry Y Wu
Rafael M Rezende
Tyler Vandeventer
P2860
P356
10.1093/INTIMM/DXU083
P577
2014-09-06T00:00:00Z